|1.||Li, Shuqin: 1 article (04/2013)|
|2.||Wang, Minghui: 1 article (04/2013)|
|3.||Chen, Yongsong: 1 article (04/2013)|
|4.||Cui, Xiuying: 1 article (04/2013)|
|5.||Yao, Herui: 1 article (04/2013)|
|6.||Jiao, Yu: 1 article (04/2013)|
|7.||Lv, Xiaobin: 1 article (04/2013)|
|8.||Song, Erwei: 1 article (04/2013)|
|9.||Lin, Ling: 1 article (04/2013)|
|10.||Hu, Haiyan: 1 article (04/2013)|
12/01/1999 - "In a recent study mast cell heparin proteoglycan (HepPG) of a cell line derived from a mouse mastocytoma was isolated. "
06/01/1997 - "We have isolated a mast cell heparin proteoglycan (MC-HepPG) from a Furth mouse mastocytoma-derived cell line that is analogous to human tissue-type mast cell HepPG. "
09/01/1987 - "Cultures of more purified mastocytoma cells (essentially devoid of macrophages) did not metabolize [35S]heparin proteoglycan to polysaccharide fragments, but instead accumulated free intact polysaccharide chains, i.e. "
09/01/1987 - "Degradation of heparin proteoglycan in cultured mouse mastocytoma cells."
09/01/1987 - "Pulse-labelling of mouse mastocytoma cell cultures, established from ascites fluid, with inorganic [35S]sulphate for 1 h yielded labelled heparin proteoglycan containing polysaccharide chains of Mr 60,000-100,000. "
05/24/2006 - "The results indicate that the MUC1 SEA domain originated from heparin sulfate proteoglycan of basement membrane (HSPG2; perlecan), an inducer of tumor cell growth. "
01/01/1992 - "We have used an extract of basement membranes which can be reconstituted into a biologically active gel matrix composed predominantly of collagen IV, laminin, nidogen, and heparin sulfate proteoglycan, in order to study the mechanisms involved in tumor cell invasion. "
04/01/1986 - "B16 amelanotic cells degraded the matrix material of bovine endothelial cell monolayers; a heparin sulfate proteoglycan appeared to be the predominant matrix component released by these tumor cells, as judged by resistance to chondroitin ABC lyase and sensitivity to heparitinase and pronase degradation. "
12/01/2007 - "While controversy over the role of carbohydrates in amyloidosis has existed since the initial recognition of amyloid, current understanding of the role of polysaccharides in the pathogenesis of amyloid deposition of Alzheimer disease and other amyloidoses is limited to studies of glyco-conjugates such as heparin sulfate proteoglycan. "
|1.||Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)
|8.||Amyloid (Amyloid Fibrils)
|1.||Drug Therapy (Chemotherapy)